These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36184716)

  • 41. A Novel Standard for Systematic Reporting of Neuroblastoma Surgery: The International Neuroblastoma Surgical Report Form (INSRF): A Joint Initiative by the Pediatric Oncological Cooperative Groups SIOPEN∗, COG∗∗, and GPOH∗∗∗.
    Matthyssens LE; Nuchtern JG; Van De Ven CP; Gabra HOS; Bjornland K; Irtan S; Stenman J; Pio L; Cross KM; Avanzini S; Inserra A; Chacon JG; Dall'igna P; Von Schweinitz D; Holmes K; Fuchs J; Squire R; Valteau-Couanet D; Park JR; Eggert A; Losty PD; La Quaglia MP; Sarnacki S;
    Ann Surg; 2022 Mar; 275(3):e575-e585. PubMed ID: 32649454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Updates in Diagnosis, Management, and Treatment of Neuroblastoma.
    Swift CC; Eklund MJ; Kraveka JM; Alazraki AL
    Radiographics; 2018; 38(2):566-580. PubMed ID: 29528815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of MR imaging and iodine 123 MIBG scintigraphy in staging of pediatric neuroblastoma.
    Hahn K; Charron M; Shulkin BL
    Radiology; 2003 Jun; 227(3):908; author reply 908-9. PubMed ID: 12773693
    [No Abstract]   [Full Text] [Related]  

  • 44. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic involvement in neuroblastoma with radiologic-pathologic correlation: a single-institution experience.
    Rosenbaum DG; Abramson SJ; DeLappe E; Teruya-Feldstein J; La Quaglia MP; Fox JJ; Price AP
    AJR Am J Roentgenol; 2013 Jul; 201(1):W141-6. PubMed ID: 23789686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines on nuclear medicine imaging in neuroblastoma.
    Bar-Sever Z; Biassoni L; Shulkin B; Kong G; Hofman MS; Lopci E; Manea I; Koziorowski J; Castellani R; Boubaker A; Lambert B; Pfluger T; Nadel H; Sharp S; Giammarile F
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):2009-2024. PubMed ID: 29938300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroblastoma: contemporary management.
    Mullassery D; Dominici C; Jesudason EC; McDowell HP; Losty PD
    Arch Dis Child Educ Pract Ed; 2009 Dec; 94(6):177-85. PubMed ID: 19933390
    [No Abstract]   [Full Text] [Related]  

  • 49. Spontaneous regression of metastases including meningeal metastasis after gross resection of primary tumor in an infant with stage 4 neuroblastoma.
    Nishio N; Mimaya J; Horikoshi Y; Okada N; Nara T; Takashima Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):537-9. PubMed ID: 16912596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR imaging in the assessment of staging of neuroblastoma.
    Leonidas JC
    Radiology; 2003 Jan; 226(1):285; author reply 285-6. PubMed ID: 12511703
    [No Abstract]   [Full Text] [Related]  

  • 51. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
    London WB; Bagatell R; Weigel BJ; Fox E; Guo D; Van Ryn C; Naranjo A; Park JR
    Cancer; 2017 Dec; 123(24):4914-4923. PubMed ID: 28885700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
    Yanik GA; Parisi MT; Shulkin BL; Naranjo A; Kreissman SG; London WB; Villablanca JG; Maris JM; Park JR; Cohn SL; McGrady P; Matthay KK
    J Nucl Med; 2013 Apr; 54(4):541-8. PubMed ID: 23440556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MR imaging of neuroblastic masses.
    Siegel MJ; Jaju A
    Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):499-513, vi. PubMed ID: 18585601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Embryonal rhabdomyosarcoma as a second malignancy following multimodal therapy for advanced-stage neuroblastoma.
    Mann GS; Byrne AT; Nadel HR; Bray H
    Pediatr Radiol; 2008 Sep; 38(9):1017-20. PubMed ID: 18594803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Similarities and controversies in imaging of pediatric renal tumors: A SIOP-RTSG and COG collaboration.
    van der Beek JN; Artunduaga M; Schenk JP; Eklund MJ; Smith EA; Lederman HM; Warwick AB; Littooij AS; Khanna G
    Pediatr Blood Cancer; 2023 May; 70 Suppl 2():e30080. PubMed ID: 36349564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Problems in the imaging of three common paediatric solid tumours.
    McHugh K; Pritchard J
    Eur J Radiol; 2001 Feb; 37(2):72-8. PubMed ID: 11223474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
    Brodeur GM; Seeger RC; Barrett A; Berthold F; Castleberry RP; D'Angio G; De Bernardi B; Evans AE; Favrot M; Freeman AI
    J Clin Oncol; 1988 Dec; 6(12):1874-81. PubMed ID: 3199170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
    Pinto N; Naranjo A; Hibbitts E; Kreissman SG; Granger MM; Irwin MS; Bagatell R; London WB; Greengard EG; Park JR; DuBois SG
    Eur J Cancer; 2019 May; 112():66-79. PubMed ID: 30947024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.